Home >> Signaling Pathways >> Microbiology & Virology >> RSV

RSV

RSV (respiratory syncytial virus) is a virus that causes respiratory tract infections.

Products for  RSV

  1. Cat.No. Product Name Information
  2. GC62750 (S)-Enzaplatovir

    (S)-BTA-C585

    (S)-Enzaplatovir ((S)-BTA-C585) is the S-enantiomer of Enzaplatovir. (S)-Enzaplatovir shows antiviral activities with an EC50 of 56 nM for respiratory syncytial viral (RSV) (patent WO2011094823A1 compound 77). (S)-Enzaplatovir  Chemical Structure
  3. GC32113 Ac-CoA Synthase Inhibitor1

    ACCS2 Inhibitor, MDK6149, VY-3-249

    Ac-CoA Synthase Inhibitor1 is a potent, reversible acetate-dependent acetyl-CoA synthetase 2 (ACSS2) inhibitor with an IC50 of 0.6 ?M. Ac-CoA Synthase Inhibitor1  Chemical Structure
  4. GC32070 ALS-8112 ALS-8112 is a potent and selective respiratory syncytial virus (RSV) polymerase inhibitor. ALS-8112  Chemical Structure
  5. GN10484 Amentoflavone

    Didemethyl Ginkgetin, NSC 295677

    Amentoflavone  Chemical Structure
  6. GC68779 BMS-433771

    BMS-433771 is an effective oral respiratory syncytial virus (RSV) inhibitor. It is effective against both A and B groups of RSV, with an EC50 mean value of 20 nM. BMS-433771 can be used for research on respiratory diseases.

    BMS-433771  Chemical Structure
  7. GC68780 BMS-433771 dihydrochloride hydrate

    BMS-433771 dihydrochloride hydrate is an effective inhibitor of respiratory syncytial virus (RSV) with oral activity. It is effective against both group A and B RSV, with an EC50 average of 20 nM. BMS-433771 dihydrochloride hydrate can be used for research on respiratory diseases.

    BMS-433771 dihydrochloride hydrate  Chemical Structure
  8. GC68883 Clesrovimab

    MK1654

    Clesrovimab (MK1654) is a fully human monoclonal antibody against respiratory syncytial virus fusion (RSV F) glycoprotein. Clesrovimab has the potential to study respiratory syncytial virus infections.

    Clesrovimab  Chemical Structure
  9. GC43377 Daphnoretin Daphnoretin is a coumarin that has been found in W. Daphnoretin  Chemical Structure
  10. GC69045 EIDD-2749

    4'-FlU; 4'-Fluorouridine

    EIDD-2749 (4'-Fluorouridine) is an orally effective RdRp inhibitor. It can effectively inhibit the replication of RSV and SARS-CoV-2. EIDD-2749 also exhibits activity against HCV and lymphocytic choriomeningitis virus (LCMV). EIDD-2749 is a promising oral candidate for COVID-19 research, as well as for other RNA viruses.

    EIDD-2749  Chemical Structure
  11. GC62955 Enzaplatovir

    BTA-C585

    Enzaplatovir (BTA-C585) is an orally bioavailable fusion inhibitor for respiratory syncytial virus (RSV) infection. Enzaplatovir  Chemical Structure
  12. GC43730 Ganglioside GM1 Asialo Mixture

    ASGM1, Asialo GM1, Gangliotetraosylceramide

    Ganglioside GM1 asialo is a component of cellular lipid rafts and can be formed by the cleavage of the sialic acid residue from ganglioside GM1 by neuraminidase. Ganglioside GM1 Asialo Mixture  Chemical Structure
  13. GC49165 GS-441524 tris-isobutyryl ester

    GS-441524 tris-isobutyryl ester

    A prodrug form of GS-441524 GS-441524 tris-isobutyryl ester  Chemical Structure
  14. GC70316 JNJ 2408068 JNJ 2408068 is a potent RSV (respiratory syncytial virus) inhibitor. JNJ 2408068  Chemical Structure
  15. GC32297 JNJ-678 (JNJ-53718678)

    JNJ-678; JNJ-53718678

    JNJ-678 (JNJ-53718678) (JNJ-678) is a novel fusion protein inhibitor. JNJ-678 (JNJ-53718678)  Chemical Structure
  16. GC71094 JNJ-8003 JNJ-8003 is a potent inhibitor of RSV Polymerase. JNJ-8003  Chemical Structure
  17. GC32087 Lumicitabine (ALS-008176)

    ALS-008176; ALS-8176

    Lumicitabine (ALS-008176) (ALS-008176) is an inhibitor of the respiratory syncytial virus (RSV) polymerase. Lumicitabine (ALS-008176)  Chemical Structure
  18. GC68286 Motavizumab

    MEDI-524

    Motavizumab  Chemical Structure
  19. GC69563 Nirsevimab

    MEDI8897

    Nirsevimab (MEDI8897) is a recombinant human respiratory syncytial virus (RSV) monoclonal antibody with a modified Fc region that extends its half-life. Nirsevimab has an affinity for RSV-B, with a Kd value of 1.5 nM. Nirsevimab can be used in RSV research.

    Nirsevimab  Chemical Structure
  20. GC68300 Palivizumab

    MEDI 493

    Palivizumab  Chemical Structure
  21. GC32300 PC786 PC786 is an inhaled respiratory syncytial virus (RSV) L protein polymerase inhibitor. PC786  Chemical Structure
  22. GC40189 Pentaacetylquercetin

    NSC 115919, Peracetylated Quercetin, Quercetin Pentaacetate

    Pentaacetylquercetin could interact with F-protein with lower binding energy and better stability to block viral adhesion. Pentaacetylquercetin  Chemical Structure
  23. GC32069 Presatovir (GS-5806)

    GS-5806

    Presatovir (GS-5806) (GS-5806) is an orally bioavailable RSV fusion inhibitor with a mean EC50 value of 0.43 nM. Presatovir (GS-5806)  Chemical Structure
  24. GC32340 RD3-0028 RD3-0028 is a potent and selective inhibitor of RSV replication with an EC50 of 4.5 μM. RD3-0028  Chemical Structure
  25. GC48036 Remdesivir-d4

    GS-5734-d4

    A neuropeptide with diverse biological activities Remdesivir-d4  Chemical Structure
  26. GC11518 Ribavirin

    NSC 163039

    Ribavirin (ICN-1229) is an antiviral agent against a broad spectrum of viruses including HCV, HIVl, and RSV.

    Ribavirin  Chemical Structure
  27. GC49395 Ribavirin-13C5 An internal standard for the quantification of ribavirin Ribavirin-13C5  Chemical Structure
  28. GC16347 Roflumilast

    B 9302107, BY 217, BYK 20869

    A PDE4 inhibitor Roflumilast  Chemical Structure
  29. GC32213 RSV-IN-1 RSV-IN-1 is a human respiratory syncytical virus (hRSV) inhibitor, with an IC50 of 0.11 μM. RSV-IN-1  Chemical Structure
  30. GC67684 RSV-IN-7 RSV-IN-7  Chemical Structure
  31. GC19313 RSV604

    A-60444

    RSV604 is a novel inhibitor of respiratory syncytial virus replication(EC50=0.86 uM); a putative RSV nucleoprotein(N) inhibitor in phase 2 clinical trials. RSV604  Chemical Structure
  32. GC37565 RSV604 R enantiomer

    A-60444 (R enantiomer)

    RSV604 R enantiomer is the R-enantiomer of RSV604. RSV604 R enantiomer  Chemical Structure
  33. GC37566 RSV604 racemate

    A-60444 racemate

    RSV604 (A-60444) racemate is a racemic mixture, shows less potency against strains of respiratory syncytial virus (RSV) than the S-isomer. RSV604 racemate  Chemical Structure
  34. GC48973 Sekikaic Acid A lichen metabolite with diverse biological activities Sekikaic Acid  Chemical Structure
  35. GC62216 Sisunatovir

    RV521

    Sisunatovir (RV521), an orally available inhibitor of the RSV fusion (RSV-F) protein, exhibits potent efficacy against a panel of clinical isolates of RSV-A and RSV-B viruses, with IC50s of 1.4 nM and 1.0 nM, respectively. Sisunatovir  Chemical Structure
  36. GC62217 Sisunatovir hydrochloride

    RV521 hydrochloride

    Sisunatovir (RV521) hydrochloride, an orally available inhibitor of the RSV fusion (RSV-F) protein, exhibits potent efficacy against a panel of clinical isolates of RSV-A and RSV-B viruses, with IC50s of 1.4?nM and 1.0?nM, respectively. Sisunatovir hydrochloride  Chemical Structure
  37. GC69974 Suptavumab

    REGN2222

    Suptavumab (REGN2222) is a human monoclonal antibody that can bind and block the conserved epitopes on both RSV A and B subtypes. Suptavumab can be used for research on RSV infection.

    Suptavumab  Chemical Structure
  38. GC17373 TMC353121

    TMC353121 is a RSV fusion inhibitor.

    TMC353121  Chemical Structure
  39. GC11893 VP-14637 inhibitor of RSV VP-14637  Chemical Structure
  40. GC38582 Ziresovir

    AK0529; RO-0529

    Ziresovir (AK0529;RO-0529) is a potent, selective, and orally bioavailable respiratory syncytial virus (RSV) fusion (F) protein (RSV F) protein inhibitor. Ziresovir  Chemical Structure

39 Item(s)

per page

Set Descending Direction